Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flurbiprofen and benzydamine hydrochloride for prevention of sore throat after laryngeal mask airway use
PACTR201812490692464Phase 4Recruiting
- Sponsor
- Mogadishu Somali Turkey Recep Tayyip Erdogan Training and Research Hospital
- Start
- Dec 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of flurbiprofen, benzydamine and saline in Post-extubation sore throat (POST) (3 arms), sponsored by Mogadishu Somali Turkey Recep Tayyip Erdogan Training and Research Hospital. Primary endpoint: Efficacy in preventing sore throat due to laryngeal mask airway application. Started Dec 2018; status: recruiting.
02
Drugs
flurbiprofenbenzydaminesaline
03
Conditions
Post-extubation sore throat (POST)
Beyond the preview
Go deeper on PACTR201812490692464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201812490692464.